Issue 14
All 53 member states of WHO's European Region unanimously adopt roadmap for AI in health care
On 2 November, the 53 member states of the WHO European Region unanimously adopted the region's first action roadmap on artificial intelligence in health care. Hungarian and Croatian analyses highlight the tasks for 2026–2033 and the governance questions.
Who is affected and how
- health policy
- National AI strategies and governance frameworks will need to be aligned with the roadmap, so it is worth mapping the gaps now.
- hospital manager
- Institutional AI governance (accountability, validation, data management) will likely be measured against this framework.
- health IT
- Procurement and compliance requirements may tighten as they are derived from the roadmap.
Lawsuit: woman reduced epilepsy medication on ChatGPT's medical advice and died
The parents have sued OpenAI, alleging that a 31-year-old software engineer reduced her epilepsy medication dose on ChatGPT's advice and suffered a fatal seizure. Hungarian-language outlets also…
doctorPatients should be explicitly advised not to change medication doses based on AI advice, and asked about their AI use.health policyThe case sharpens questions of liability and regulation around consumer AI health advice.incident · United StatesPhishing attack on AI firm Xsolis exposes data tied to 1.4 million patients; nine health systems report impact
A phishing attack on healthcare AI company Xsolis exposed data linked to 1.4 million patients. Nine health systems reported that they were affected.
hospital managerData-handling and incident-reporting obligations of third-party AI vendors must be set out in contracts and also verified in practice.health ITPhishing protection across the supply chain and segmentation of access rights are priority risk-management tasks.insurance · United StatesElectronic Frontier Foundation criticizes Medicare's AI prior authorization pilot over delays and denials
The Electronic Frontier Foundation says the WISeR pilot hands seniors' access to care to private companies without transparency, testing or legal limits. Reports describe delays and denials in…
doctorDocumenting and appealing prior authorization denials may mean extra work.health policyTransparency, testing and appeal rights in the pilot are at the center of the policy debate.hospital managerDelays and denials from payer AI decisions create financial and care-delivery risks.tool · globalChatGPT could soon analyse Health Connect and Google Health data on Android
According to signs in the app's code, ChatGPT could soon access data stored on Android and available through Health Connect, and connect to Google Health. OpenAI says connected health data and…
doctorPatients may increasingly bring AI-analysed wearable data with them; it is worth asking about its clinical value and data source.health ITLinking consumer AI tools with health data sources raises privacy and interoperability questions.Hungary
More key stories of the week
Isomorphic Labs in talks to raise about $5 billion for AI drug discovery
Alphabet-owned Isomorphic Labs is seeking about $5 billion for AI-based drug discovery, according to Bloomberg, while Dealroom reports a $50 billion valuation. Speaking at Bloomberg Tech in London on…
pharmaceuticalsThe fundraising could intensify competition among AI-native players for partnerships and talent, and the first human trials will serve as a benchmark.research · globalStudies and professional bodies warn of harmful mental health and medical advice from AI chatbots
New studies and psychologists say AI chatbots can pose serious mental health risks, and older people are advised to be cautious about health advice from them. The UK's NHS Alliance welcomed the…
doctorIt is worth discussing separately with patients which AI tools they use for their mental health problems.health policyThe need for safeguards on the use of consumer chatbots for mental health is growing.research · United StatesAnthropic expands into life sciences: Johns Hopkins technology, drug discovery and clinical trial design
Johns Hopkins' AstroPath tumor-mapping technology has been selected for an Anthropic AI project, and the company has written about using Claude in drug discovery and clinical trials. Hungarian media…
pharmaceuticalsAI support for trial design, document review and molecule search may speed up development steps, but it must be validated.doctorAI-based mapping of tumor tissue points to a new toolkit for pathology and oncology research.drug development · globalRoche partners with Chai Discovery to deploy Chai-3 model across its pipelines
Roche and Chai Discovery announced on 5 November that the Chai-3 model will be deployed across Roche's global therapeutic pipelines. The deal extends Chai's run of AI drug discovery agreements.
pharmaceuticalsAnother example of large companies integrating external AI molecule-design platforms into their in-house pipelines.case · United StatesWhere the human-AI workflow in health care breaks down: hospitals should examine their tech stacks first
Analyses say healthcare AI struggles with workflows, system connectivity and standardization. They recommend that, before buying more AI tools, hospitals assess their existing technology stack.
hospital managerBefore procurement, integrations and data quality need to be reviewed, because the value of an AI tool depends on them.health ITRecord integration and terminology standardization are prerequisites for diagnostic AI.incident · United StatesIllinois hospitals drill for AI-driven cyberattack as security leaders outline AI agent risks
Illinois hospitals held a drill against an AI-driven cyberattack on 5 November. Security leaders at Erlanger, Atlantic Health and Lexington Health listed six risks tied to AI agents, such as forged…
hospital managerAI agents' access must be managed as strictly as that of human users, and drills must be built into plans.health ITAgent identity management, permissions and vendor access should be brought under a separate control framework.licensing · United StatesFDA clears Neurotronics' AI-based sleep analysis software
Neurotronics received FDA clearance for its AI-based sleep analysis software on 4 November. MobiHealthNews reported the decision.
doctorAutomating the analysis used in sleep diagnostics may partly replace manual scoring, but clinical validation is still required.medtech companyAnother 510(k)-type reference for the regulatory pathway of AI-based software products.clinical deployment · United KingdomNHS trials AI phone assistant for long-term conditions; Barts adds AI to breast cancer MDTs; Palantir tools underused
The NHS is trialling an AI phone assistant to monitor patients with long-term conditions, and Barts Health is introducing AI decision support in breast cancer multidisciplinary team meetings. A…
doctorMultidisciplinary team decision support and remote monitoring are being built into everyday care pathways.hospital managerUnused tools show that procurement alone is not enough; the rollout plan and actual use must be measured too.health ITActual use and value delivered by vendor platforms must be demonstrated.drug development · globalDrugmaker CEOs doubt AI's promise to cure disease as Sanofi halts a Nurix-partnered program
According to The Wall Street Journal, drugmaker CEOs are not buying Silicon Valley's AI promises, and some biotech startups are deliberately skipping AI in discovery. Nurix said Sanofi has…
pharmaceuticalsAI-derived candidates must show clinical evidence; promises do not automatically turn into pipeline value.tool · United StatesAthenahealth launches tool to let patients ask Anthropic's Claude about their health records
Athenahealth launched a tool on November 2 that lets patients query their health records through Anthropic's Claude. The integration connects patient-portal data with the consumer AI assistant.
doctorPatients may arrive with lab results and questions interpreted by an AI assistant, so physicians should be prepared to explain them.health ITConnecting EHR data to external AI assistants creates access, audit-logging and consent-management tasks.regulation · United StatesAI vendors and health systems may share liability with physicians for clinical AI, AMA says
Legal experts say that, alongside developers and physicians, the health care organizations that deploy clinical AI may also be liable for it. Modern Healthcare also covered the legal risks facing…
hospital managerContracts and deployment processes must set out who bears responsibility when AI tools fail.doctorFollowing or overriding an AI recommendation should be documented, because liability is shared.regulation · United StatesStakeholders offer competing views on how FDA should regulate generative AI in medtech
On November 3, industry stakeholders set out differing positions on how the FDA should regulate generative AI in medical technology. Five views show the main lines of the debate.
medtech companyApproval strategies for generative AI products must be adjusted as the FDA's approach evolves.health policyIn shaping the regulatory framework, the challenge is balancing the differing interests of stakeholders.In brief
Collections
Hungarian and Central European stories: domestic companies, institutions, surveys, regulation.
Regulatory approvals, regulation of AI medical devices, and health policy decisions.
Hospitals and clinics where AI has become part of patient care: what works and what doesn't.
Clinical trials, diagnostic research and AI-based drug development.
Narratives
The AI scribe returns time to doctors
Ambient AI notetakers are described as the most significant change in clinical documentation in a generation: they reduce documentation time and may mitigate burnout.
→ lasting · evidence: moderateDeployment is faster than evidence
The number of FDA-approved AI tools is growing rapidly, and hospitals use them widely. Meanwhile, clinical benefits have been studied in less than 1% of tools, while hospital testing and oversight often lag behind.
↗ rising · evidence: moderatePatients now start with AI
The chatbot is increasingly the first port of call for more patients on health matters: patients use AI to interpret their test results, and consumer AI assistants are beginning to connect directly to patient records.
▲ at peak · evidence: moderateChatbot therapists put young people at risk.
Young people are turning en masse to chatbots for mental support. Unvalidated bots, according to studies, can accelerate delusions and mania, often fail in crises, and, according to lawsuits, have played a role in deaths. Therefore, they need regulation.
▲ at peak · evidence: weakAI is rewriting drug development
With the entry of tech and frontier companies, AI has become a new engine for drug discovery: AI agents and virtual biotech firms are working on drug candidates, and the first AI-designed drug is in Phase III trials.
▲ at peak · evidence: moderateThe algorithm denies care
Insurers and Medicare use AI to deny and delay care, with patients paying the price; human decision-making must be mandated by law.
▲ at peak · evidence: weakAI already diagnoses better
In difficult cases, AI is more than twice as accurate as experienced doctors, with lower examination costs, making it time to treat it as a doctor.
↗ rising · evidence: weakAI must be licensed as a doctor
Generative AI must be qualified based on competence, similar to doctors, and can perform clinical tasks without real-time medical supervision if appropriate safeguards are in place.
→ lasting · evidence: moderateNurses are introducing AI without involving them
Nurses and their unions say hospitals are implementing AI without bedside reviews or consulting nurses. They argue AI interferes with nursing judgment and scheduling, displacing nurses.
→ lasting · evidence: moderateAI does not replace but transforms the doctor
AI does not eliminate doctors, especially radiologists, but transforms their work: machines handle routine tasks, while humans retain judgment and responsibility.
→ lasting · evidence: strongEurope delays, supervision shifts to lifecycle
The EU is simplifying and postponing high-risk requirements for healthcare AI until 2027–2028. Meanwhile, the UK is shifting focus from pre-market regulation to lifecycle oversight, while the WHO European Region has adopted a joint action roadmap.
↗ rising · evidence: moderateThe AI agent as the hospital's new risk
AI accelerates attacks on hospitals, AI agents bypass controls, and staff upload patient data into unauthorized AI tools, making cybersecurity a patient safety issue.